MediClin H1 FY26 EBIT climbs 19.2% to EUR 26.6 million; revenue rises 5% to EUR 386.4 million

• MediClin posted H1 2026 revenue of EUR 386.4 million, up 5% year over year; EBIT climbed to EUR 26.6 million.
• Patients treated rose to 54,708, up from the prior-year period.
• Post-Acute revenue increased 4.6% to EUR 263 million; EBIT rose to EUR 25.6 million as the cost of materials ratio fell 1 percentage point.
• Acute Care revenue grew to EUR 111.2 million, while EBIT was unchanged at an operating loss of EUR 1.1 million.
• Management kept its full-year outlook for revenue growth of 3.5%-6.5% and EBIT of EUR 57 million-EUR 72 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediClin AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2374572_en) on July 30, 2026, and is solely responsible for the information contained therein.